Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Frequently Asked Questions
Vitiligo and Pregnancy
The reassuring news is that vitiligo alone generally does not make pregnancy unsafe. Most women appear to remain stable during pregnancy, some improve, and some worsen.
There are, however, a few things worth knowing: pregnancy can affect disease activity, some treatments need to be reviewed, vitiligo sometimes travels with thyroid disease, and several large studies have found a modest association with miscarriage.
Here are the practical answers.
Don’t panic and don’t abruptly stop prescription treatment on your own. Review your medications with the clinician managing the pregnancy and, where appropriate, your dermatologist.
Is pregnancy riskier if I have vitiligo?
Usually not dramatically so.
Several large observational studies have found a modestly higher rate of spontaneous miscarriage among women with vitiligo. However, other pregnancy outcomes — including preterm delivery, pre-eclampsia, gestational diabetes, stillbirth and fetal growth restriction — have not shown the same consistent increase.
This does not mean that vitiligo causes miscarriage. Other autoimmune conditions, particularly thyroid disease, may contribute, and large population studies cannot account perfectly for every difference between women.
Will vitiligo flare during pregnancy?
Most women appear to stay stable.
A 2026 systematic review found that, in the limited studies available, about 65% remained stable, roughly 12% improved and around 20% reported worsening during pregnancy.
These figures should be treated as estimates rather than predictions. Surprisingly few good studies have followed vitiligo through pregnancy, and the available research includes only small numbers of women.
What happens to vitiligo after childbirth?
Most women still appear to remain stable after delivery, but postpartum worsening does occur.
Small studies suggest that roughly 63–66% remain stable postpartum, while around 17–28% experience worsening.
Childbirth is a major hormonal and immune transition, so some change is biologically plausible. It is reasonable to keep an eye on previously active vitiligo during the first months after delivery.
Of course, three new spots on an elbow may not rank very high on the priority list while trying to keep a six-week-old human alive.
Should I have my thyroid checked?
Vitiligo is associated with autoimmune thyroid disease, and significant untreated thyroid dysfunction matters during pregnancy.
That does not mean every person with vitiligo automatically needs every thyroid test available.
Tell your obstetrician, family physician or other pregnancy-care clinician that you have vitiligo, particularly if you also have symptoms of thyroid disease, previous abnormal thyroid results, another autoimmune condition, a family history of thyroid disease, fertility problems or previous pregnancy loss.
They can decide which tests, if any, are appropriate for you.
Can vitiligo treatments harm a pregnancy?
Some treatments are compatible with pregnancy; others need to be stopped or reconsidered.
Generally considered one of the more pregnancy-compatible vitiligo treatments. Folic-acid intake is worth discussing with your clinician.
Can often be used on limited areas. Very potent steroids used in large cumulative amounts deserve more caution.
Pregnancy data remain limited. Current European labeling says it should not be used during pregnancy or breastfeeding. U.S. labeling states that available human pregnancy data are insufficient.
Oral PUVA is considered contraindicated during pregnancy.
Oral steroids and other immune-modifying treatments require individual assessment.
Do not assume that “I stopped everything immediately” is automatically the safest approach. If you discover a pregnancy while using prescription treatment, contact your doctor and review the exposure.
What if I was using Opzelura when I discovered I was pregnant?
Contact the prescribing physician and the clinician managing your pregnancy.
An exposure before you knew you were pregnant is not the same thing as evidence that harm has occurred. Current pregnancy data for topical ruxolitinib are limited, which is why medical review is appropriate.
European labeling states that Opzelura should not be used during pregnancy. In the United States, the prescribing information states that available human data are insufficient to determine drug-associated pregnancy risk.
In other words: call your doctor rather than catastrophizing.
What if the pregnancy was unexpected?
Unexpected pregnancies happen, including while people are taking medications that may need to be reconsidered.
Write down everything you are currently using: prescription creams, tablets, injections, supplements, home phototherapy and over-the-counter products.
Then review the list with your pregnancy-care clinician and dermatologist.
Do not conduct an overnight pharmacology review on Google and assume the worst.
What is the chance that my child will inherit vitiligo?
Vitiligo is hereditary, but not in the simple way that blood type or some single-gene disorders are inherited.
It is a polygenic, multifactorial condition: many genetic variants contribute to susceptibility, while immune regulation, environmental influences and biological chance also play roles.
If one parent has vitiligo, estimates of the child’s lifetime risk are usually around 5–7%.
What if both parents have vitiligo?
Having two affected parents would reasonably be expected to increase a child’s genetic susceptibility, but the numbers do not simply add together.
Vitiligo involves many genes, and we do not currently have a reliable percentage that can predict an individual child’s risk when both parents are affected.
Identical-twin studies illustrate the problem nicely: even two people sharing essentially the same DNA do not always both develop vitiligo.
Can vitiligo affect a woman’s fertility?
There is no convincing evidence that loss of pigment itself reduces female fertility.
If someone with vitiligo is having difficulty becoming pregnant, the usual fertility evaluation is appropriate rather than assuming vitiligo is the cause.
Associated conditions — particularly thyroid disease — may sometimes be more relevant to reproductive health than vitiligo itself.
Does vitiligo affect male fertility?
There is no good evidence that men with vitiligo are generally infertile.
A few small studies have examined semen quality and reproductive hormones in men with vitiligo. Some found lower progressive sperm motility, and one study also reported differences in sperm concentration and morphology.
Another small study found no significant difference in sperm concentration or morphology but did find lower progressive motility in men with vitiligo.
These studies are too small and observational to show that vitiligo itself causes infertility. Importantly, an abnormal semen parameter does not automatically mean that a man is infertile.
Researchers are interested in the question because inflammation and oxidative stress — both relevant to vitiligo biology — can potentially affect sperm function. But this remains a hypothesis rather than a clinically established consequence of vitiligo.
Can we test an unborn baby for vitiligo?
Not in a clinically useful way.
There is no single “vitiligo gene.” Ordinary vitiligo results from a combination of many susceptibility genes and non-genetic factors.
Current genetic testing therefore cannot reliably tell parents whether a fetus will or will not develop vitiligo later in life.
Is there a special diet or supplement for pregnancy with vitiligo?
No special “vitiligo pregnancy diet” has been shown to prevent progression, miscarriage or transmission of vitiligo to a child.
Follow the usual nutritional and prenatal advice given for pregnancy, including folic acid according to local medical guidance.
If you use supplements or herbal products, tell your clinician. “Natural” does not automatically mean appropriate during pregnancy.
Can I treat vitiligo while breastfeeding?
Often, yes — but treatment needs to be reviewed again after delivery.
NB-UVB is generally considered compatible with breastfeeding. Limited topical corticosteroids can usually be used with appropriate precautions, particularly avoiding medication where an infant could directly ingest it from the skin.
Current European labeling states that ruxolitinib cream (Opzelura) should not be used during breastfeeding.
If vitiligo becomes active after delivery, check before simply restarting whatever you used before pregnancy.
My first pregnancy was easy. Will the second one be the same?
An uncomplicated first pregnancy is reassuring, but it is not a guarantee.
Age, thyroid status, vitiligo activity, medications and general health may all be different the second time around.
And, of course, pregnancy number two generally arrives in a household already containing child number one.
The useful questions remain simple: Is my vitiligo active? Do I have another autoimmune condition? What medications am I using? Did I have complications previously? And does anything need reviewing before or early in pregnancy?
A very short pregnancy checklist
- Tell your dermatologist you are planning a pregnancy.
- Review every treatment — including creams and supplements.
- Tell your pregnancy-care clinician that you have vitiligo and discuss whether thyroid testing is appropriate.
- Take standard preconception folic acid according to local medical guidance.
- Mention previous miscarriage, thyroid disease or pregnancy complications.
- Think ahead to breastfeeding when discussing which treatments can be restarted after delivery.
Want the longer version?
Prefer to listen?
Jukema MR, Gianotten E, Denswil NP, et al. The Impact of Pregnancy on the Course of Vitiligo—A Systematic Review . JEADV Clinical Practice. 2026.
International Vitiligo Task Force. Worldwide expert recommendations for the diagnosis and management of vitiligo .
Eissa MST, Sallam MAA, Soleit MAKO. Exploring the Relationship between Vitiligo and Male Fertility . QJM. 2024.
Semen analysis results are negatively affected in patients with vitiligo: a cross-sectional study . Human Reproduction. 2022.
Updated on October 16, 2026
FAQOther Questions
- Shall I take vitamin D for my vitiligo?
Vitamin D plays a central role in the prevention of different inflammatory and chronic diseases. Consuming 1,000–4,000 IU (25–100 mcg) of vitamin D3 daily should be ideal for mo...
- Vitiligo trials for kids: basics for the parents
Pediatric vitiligo trials · The basics Two parallel studies are evaluating investigational use of ruxolitinib cream in young children — researchers are still finding out how wel...
- Is it Bitiligo? Vitaligo? Veteligo?
There are so many different ways that people try and spell or even pronounce Vitiligo. Here are some common mis-spellings: bitiligo, vitigo, vitaligo, vitilago, vitiglio, vitag...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.